Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 737.71

+4.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (200)	1/26/1998 10:32:00 PM
From: Miljenko Zuanic	of 3559

Rick: >>Potential (not compelling at this point) negative...... at $7 7/8 asked, it's certain that the angiopoietins aren't making anyone's radar and that obesity is not flying.<< This is ridiculous cheap price. Today bt sector investors (who was smart to spare cash <grrrr>) have anrepeatable opportunity. Angiopoietins for revascularization is my favor. Follow Oxokime (combination of BDNF and NGF) and MUSK. REGN is very quiet and they are silently doing job. One day, I hope very soon, this silence will be broken (REGN continue to publicize their results in per-view journals): "An Orphan Receptor Tyrosine Kinase Family Whose Memebers Serve as Nonintegrin Collagen Receptors, Molecular Cell, Vol 1. Num 1, December 1997", and we will be bombarded with R%D news. At that point air will be crowded with antennas. Cheers, mz

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next